Intrinsic Value of S&P & Nasdaq Contact Us

Marsh & McLennan Companies, Inc. MRSH NYSE

NYSE • Financial Services • Insurance - Brokers • US • USD

SharesGrow Score
66/100
4/7 Pass
SharesGrow Intrinsic Value
$197.00
+14%
Analyst Price Target
$212.82
+23.1%

Marsh & McLennan Companies, Inc. (MRSH) is a Insurance - Brokers company in the Financial Services sector, currently trading at $172.85. It has a SharesGrow Score of 66/100, indicating a above average investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of MRSH = $197.00 (+14% from the current price, the stock appears fairly valued). Analyst consensus target is MRSH = $213 (+23.1% upside).

Valuation: MRSH trades at a trailing Price-to-Earnings (P/E) of 20.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.2.

Financials: revenue is $27.0B, +9.2%/yr average growth. Net income is $4.2B, growing at +11.2%/yr. Net profit margin is 15.4% (healthy). Gross margin is 42.3% (+0.6 pp trend).

Balance sheet: total debt is $21.4B against $15.1B equity (Debt-to-Equity (D/E) ratio 1.42, moderate). Current ratio is 1.1 (adequate). Debt-to-assets is 36.5%. Total assets: $58.7B.

Analyst outlook: 12 / 34 analysts rate MRSH as buy (35%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 48/100 (Partial), Growth 73/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 73/100 (Pass), Future 46/100 (Partial), Income 70/100 (Pass).

$212.82
▲ 23.12% Upside
Average Price Target
Based on 34 Wall Street analysts offering 12-month price targets for Marsh & McLennan Companies, Inc., the average price target is $212.82, with a high forecast of $257.00, and a low forecast of $190.00.
Highest Price Target
$257.00
Average Price Target
$212.82
Lowest Price Target
$190.00

MRSH SharesGrow Score Overview

66/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 48/100
Valuation — P/E, PEG, Forward PEG
GROWTH 73/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 73/100
Gross margin is + market cap
FUTURE 46/100
Analyst outlook — as buy
INCOME 70/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MRSH

~
VALUE Partial
48/100
MRSH trades at a trailing Price-to-Earnings (P/E) of 20.3 (S&P 500 average ~25). Forward PEG 2.2 — overvalued. Trailing PEG 18.95. Analyst consensus target is $213, implying +23.2% from the current price $173. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
73/100
MRSH: +9.2%/yr revenue is, +11.2%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
MRSH: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet MRSH: Debt-to-Equity (D/E) ratio 1.42 (moderate), Current ratio is 1.1 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Pass
73/100
MRSH: Gross margin is 42.3% (+0.6 pp trend), $84B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 73/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
46/100
Analyst outlook: 12 / 34 analysts rate MRSH as buy (35%). Analyst consensus target is $213 (+23.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
70/100
MRSH: Net profit margin is 15.4%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range164.89-239.34
Volume1.76M
Avg Volume (30D)3.2M
Market Cap$83.68B
Beta (1Y)0.75
Dividend Yield$2.7000
Share Statistics
EPS (TTM)8.48
Shares Outstanding$487M
IPO Date1987-12-30
Employees90,000
CEOJohn Quinlan Doyle
Financial Highlights & Ratios
Revenue (TTM)$26.98B
Gross Profit$11.4B
EBITDA$7.4B
Net Income$4.16B
Operating Income$6.22B
Total Cash$2.69B
Total Debt$21.45B
Net Debt$18.76B
Total Assets$58.71B
Price / Earnings (P/E)20.4
Price / Sales (P/S)3.1
Analyst Forecast
1Y Price Target$210.00
Target High$257.00
Target Low$190.00
Upside+21.5%
Rating ConsensusHold
Analysts Covering34
Buy 35% Hold 62% Sell 3%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS5717481023

Price Chart

MRSH
Marsh & McLennan Companies, Inc.  ·  NYSE
Financial Services • Insurance - Brokers
164.89 52WK RANGE 239.34
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message